| Product Code: ETC13312615 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Drug Repurposing Market was valued at USD 26.5 Billion in 2024 and is expected to reach USD 43.9 Billion by 2031, growing at a compound annual growth rate of 5.06% during the forecast period (2025-2031).
The Global Drug Repurposing Market involves the identification and development of existing drugs for new therapeutic applications. This market is driven by factors such as the need for cost-effective drug development, shortened timelines for drug approvals, and the increasing prevalence of chronic diseases. Drug repurposing offers advantages such as reduced risks of failure in clinical trials, lower development costs, and opportunities for rapid entry into the market. Key players in the market include pharmaceutical companies, biotechnology firms, academic institutions, and research organizations. The market is witnessing growth due to advancements in technology, increased collaborations for research, and the exploration of drug combinations for complex diseases. Regulatory support for drug repurposing initiatives and the rising demand for personalized medicine are expected to further drive market expansion globally.
The Global Drug Repurposing Market is experiencing significant growth driven by the increasing demand for efficient and cost-effective drug development strategies. The trend of repurposing existing drugs for new therapeutic indications has gained momentum due to the potential to reduce development costs and timelines. Opportunities in this market lie in the exploration of novel drug combinations, partnerships between pharmaceutical companies and research institutions, and the application of artificial intelligence and data analytics to identify new uses for existing drugs. Additionally, the rising prevalence of chronic diseases and the need for rapid drug approvals further fuel the growth of the drug repurposing market. Overall, the market presents promising opportunities for stakeholders looking to capitalize on the potential of repurposing existing drugs for new treatments.
One of the main challenges faced in the Global Drug Repurposing Market is the lack of clear regulatory pathways for repurposed drugs. Repurposing existing drugs for new indications often requires navigating complex regulatory processes, including demonstrating safety and efficacy for the new use. Additionally, intellectual property rights can be a hurdle, as obtaining new patents for repurposed drugs may not always be feasible. Another challenge is the high cost and lengthy timelines associated with conducting clinical trials for repurposed drugs, which can hinder the adoption of these drugs in the market. Overall, overcoming these challenges requires collaboration between industry stakeholders, regulatory bodies, and researchers to streamline the drug repurposing process and bring innovative therapies to patients efficiently.
The Global Drug Repurposing Market is primarily driven by the increasing prevalence of various diseases and the urgent need for effective treatments. Drug repurposing offers a cost-effective and time-efficient approach to drug development by leveraging existing drugs for new therapeutic indications, thereby reducing the time and resources required for new drug discovery. Additionally, the rising demand for personalized medicine and the growing focus on precision healthcare are driving the adoption of drug repurposing strategies as a way to tailor treatments to individual patient needs. Furthermore, the expanding availability of large-scale data analytics and artificial intelligence technologies is enhancing the identification of potential drug candidates for repurposing, fueling market growth.
Government policies related to the Global Drug Repurposing Market vary by country but generally focus on promoting innovation and incentivizing the repurposing of existing drugs for new therapeutic uses. Many governments provide funding and grants for research and development in drug repurposing, as well as streamlined regulatory pathways to expedite the approval process for repurposed drugs. Additionally, some countries offer tax incentives or patent extensions to encourage pharmaceutical companies to invest in repurposing efforts. Overall, government policies aim to stimulate the growth of the Global Drug Repurposing Market by reducing barriers to entry and fostering a supportive environment for drug repurposing research and development.
The Global Drug Repurposing Market is poised for significant growth in the coming years as pharmaceutical companies and researchers increasingly look to repurpose existing drugs for new therapeutic indications. With the rising costs and lengthy timelines associated with developing new drugs, drug repurposing offers an attractive alternative by leveraging existing safety data and accelerating the drug development process. The growing prevalence of chronic diseases, the availability of large datasets for drug discovery, and advancements in artificial intelligence and machine learning are expected to further drive the expansion of the market. Additionally, the impact of the COVID-19 pandemic has underscored the importance of repurposing existing drugs for new infectious diseases, presenting new opportunities for market growth in the future.
In the Global Drug Repurposing Market, Asia is expected to witness significant growth due to the increasing focus on research and development activities in countries like China and India. North America is projected to dominate the market, driven by the presence of key pharmaceutical companies and favorable regulatory environment. Europe is also a major player in the market, with initiatives promoting drug repurposing and collaborations between academic institutions and industry players. In the Middle East and Africa region, the market is growing steadily, supported by government investments in healthcare infrastructure. Latin America is anticipated to experience moderate growth, with rising awareness about the benefits of drug repurposing among healthcare professionals and patients driving market expansion.
Global Drug Repurposing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Drug Repurposing Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Drug Repurposing Market Revenues & Volume, 2021 & 2031F |
3.3 Global Drug Repurposing Market - Industry Life Cycle |
3.4 Global Drug Repurposing Market - Porter's Five Forces |
3.5 Global Drug Repurposing Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Drug Repurposing Market Revenues & Volume Share, By Approach, 2021 & 2031F |
3.7 Global Drug Repurposing Market Revenues & Volume Share, By Disease Area, 2021 & 2031F |
3.8 Global Drug Repurposing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Global Drug Repurposing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Global Drug Repurposing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Drug Repurposing Market Trends |
6 Global Drug Repurposing Market, 2021 - 2031 |
6.1 Global Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Drug Repurposing Market, Revenues & Volume, By On-Target Repurposing, 2021 - 2031 |
6.1.3 Global Drug Repurposing Market, Revenues & Volume, By Off-Target Repurposing, 2021 - 2031 |
6.1.4 Global Drug Repurposing Market, Revenues & Volume, By Combination Drug Repurposing, 2021 - 2031 |
6.1.5 Global Drug Repurposing Market, Revenues & Volume, By Pathway-Based Repurposing, 2021 - 2031 |
6.2 Global Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Drug Repurposing Market, Revenues & Volume, By Oncology, 2021 - 2031 |
6.2.3 Global Drug Repurposing Market, Revenues & Volume, By Neurodegenerative Diseases, 2021 - 2031 |
6.2.4 Global Drug Repurposing Market, Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031 |
6.2.5 Global Drug Repurposing Market, Revenues & Volume, By Infectious Diseases, 2021 - 2031 |
6.3 Global Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Drug Repurposing Market, Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031 |
6.3.3 Global Drug Repurposing Market, Revenues & Volume, By Biotechnology Firms, 2021 - 2031 |
6.3.4 Global Drug Repurposing Market, Revenues & Volume, By Academic Research Institutes, 2021 - 2031 |
6.3.5 Global Drug Repurposing Market, Revenues & Volume, By Contract Research Organizations (CROs), 2021 - 2031 |
6.4 Global Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Drug Repurposing Market, Revenues & Volume, By Computational Drug Repurposing, 2021 - 2031 |
6.4.3 Global Drug Repurposing Market, Revenues & Volume, By High-Throughput Screening, 2021 - 2031 |
6.4.4 Global Drug Repurposing Market, Revenues & Volume, By Biomarker-Based Repurposing, 2021 - 2031 |
6.4.5 Global Drug Repurposing Market, Revenues & Volume, By AI & Machine Learning in Drug Repurposing, 2021 - 2031 |
7 North America Drug Repurposing Market, Overview & Analysis |
7.1 North America Drug Repurposing Market Revenues & Volume, 2021 - 2031 |
7.2 North America Drug Repurposing Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Drug Repurposing Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Drug Repurposing Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Drug Repurposing Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
7.4 North America Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
7.5 North America Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6 North America Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
8 Latin America (LATAM) Drug Repurposing Market, Overview & Analysis |
8.1 Latin America (LATAM) Drug Repurposing Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Drug Repurposing Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Drug Repurposing Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Drug Repurposing Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Drug Repurposing Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Drug Repurposing Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
8.4 Latin America (LATAM) Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
8.5 Latin America (LATAM) Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
8.6 Latin America (LATAM) Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
9 Asia Drug Repurposing Market, Overview & Analysis |
9.1 Asia Drug Repurposing Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Drug Repurposing Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Drug Repurposing Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Drug Repurposing Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Drug Repurposing Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Drug Repurposing Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
9.4 Asia Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
9.5 Asia Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
9.6 Asia Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
10 Africa Drug Repurposing Market, Overview & Analysis |
10.1 Africa Drug Repurposing Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Drug Repurposing Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Drug Repurposing Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Drug Repurposing Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Drug Repurposing Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Drug Repurposing Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
10.4 Africa Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
10.5 Africa Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
10.6 Africa Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
11 Europe Drug Repurposing Market, Overview & Analysis |
11.1 Europe Drug Repurposing Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Drug Repurposing Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Drug Repurposing Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Drug Repurposing Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Drug Repurposing Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Drug Repurposing Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
11.4 Europe Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
11.5 Europe Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
11.6 Europe Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
12 Middle East Drug Repurposing Market, Overview & Analysis |
12.1 Middle East Drug Repurposing Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Drug Repurposing Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Drug Repurposing Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Drug Repurposing Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Drug Repurposing Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
12.4 Middle East Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
12.5 Middle East Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
12.6 Middle East Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
13 Global Drug Repurposing Market Key Performance Indicators |
14 Global Drug Repurposing Market - Export/Import By Countries Assessment |
15 Global Drug Repurposing Market - Opportunity Assessment |
15.1 Global Drug Repurposing Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Drug Repurposing Market Opportunity Assessment, By Approach, 2021 & 2031F |
15.3 Global Drug Repurposing Market Opportunity Assessment, By Disease Area, 2021 & 2031F |
15.4 Global Drug Repurposing Market Opportunity Assessment, By End User, 2021 & 2031F |
15.5 Global Drug Repurposing Market Opportunity Assessment, By Technology, 2021 & 2031F |
16 Global Drug Repurposing Market - Competitive Landscape |
16.1 Global Drug Repurposing Market Revenue Share, By Companies, 2024 |
16.2 Global Drug Repurposing Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here